| Financial Year |
March 31 2018 |
| Monetary Funds |
549,711,796.09 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
160,651,721.84 |
| Advances to Suppliers |
1,010,647.85 |
| Other Receivables |
426,434,774.42 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,928,751,055.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
31,688,158.96 |
| Total Current Assets |
3,098,248,154.16 |
| Available-for-Sale Financial Asset |
1,577,108,162.21 |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
100,780,061.13 |
| Investment Properties |
211,759,217.62 |
| Fixed Assetes |
42,160,404.13 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
820,996.89 |
| R&D expenses |
-- |
| Goodwill |
366,827.91 |
| Long-Term Deferred and Prepaid Expenses |
19,923,598.27 |
| Deferred Income Tax Assets |
12,311,203.34 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,965,230,471.50 |
| Total Assets |
5,063,478,625.66 |
| Short-Term Loans |
266,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
34,824,198.37 |
| Accounts Received In Advance |
1,047,843,554.44 |
| Employee Compensation Payable |
13,217,711.60 |
| Taxes Payable |
67,174,138.22 |
| Interest Payable |
1,169,282.25 |
| Dividend Payable |
-- |
| Other payables |
393,942,766.02 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
712,903,470.00 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
2,537,075,120.90 |
| Long-term Loans |
339,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,677,629.50 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
102,231,647.39 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
446,787,318.34 |
| Total Liabilities |
2,983,862,439.24 |
| Paid-In Capital(Or Share Stock) |
433,540,800.00 |
| Capital Surplus |
188,680,303.44 |
| Surplus Reserve |
63,570,911.94 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,220,488,518.55 |
| Minority Stockholder's Interest |
59,543,295.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,020,072,891.05 |
| Owner's Equity（Stockholder's Equity） |
2,079,616,186.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,063,478,625.66 |
